The Internation Hearing Loop Manufacturers Association - IHLMA

SHEFFIELD, ENGLAND — Rinri Therapeutics, a biotechnology company developing a novel stem cell therapy to restore hearing, today announces that it has raised a total of £10 million) from existing investors Boehringer Ingelheim Venture Fund (BIVF), UCB Ventures and BioCity alongside the UK Government Future Fund.

The proceeds will support the development of the company’s novel stem cell therapy to reverse sensorineural hearing loss (SNHL).

Rinri Therapeutics Raises £10 million to Advance Stem Cell Therapy Hearing Loss Treatment

Contact
IHLMA

For all general, membership and technical enquiries, please contact:

admin@ihlma.org

+44 (0) 118 954 2175

Features

International Hearing Loop Manufacturers Association

PO Box 3251
Gloucester
Gloucestershire
GL1 9FU
United Kingdom